The PEPperCHIP® Transglutaminase Microarray is based on 6 transglutaminase variants (hFXIII, hTG1, hTG2, hTG3, hTG4 and hTG6) and can be used for
- high resolution epitope mapping of anti-transglutaminase antibodies
- antibody specificity analysis with 6 different transglutaminase antigens
- serum antibody screening for anti-transglutaminase antibodies
- isotype-specific IgG and IgA profiling from serum and plasma
- correlation of anti-transglutaminase antibody responses with pathogenesis
The standard slide format of PEPperCHIP
® Transglutaminase Microarrays facilitates application with standard lab infrastructures and most microarray scanners. Additional PEPperCHIP
® Accessories support the straightforward use of the state-of-the-art peptide microarray solutions to ensure optimized assay conditions and best data quality.
Read more about PEPperCHIP Epitope Mapping Poster presentation at GRC, 2016 (Girona, Spain)
Dr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
Dr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
Reversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
Press release: Zedira announces ISO 9001:2015 certification
Design of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
Microbial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering